139050 — BFLabs Co Income Statement

0.000.00%

Last trade - 00:00

TechnologySpeculativeMicro Cap

Annual income statement for BFLabs Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	36,984	39,231	28,355	28,565	17,198
Cost of Revenue
Gross Profit	8,706	7,694	3,730	12,137	7,500
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	39,944	50,058	35,818	45,918	31,695
Operating Profit	-2,960	-10,827	-7,463	-17,353	-14,496
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-8,502	-7,952	-20,159	-308	-23,414
Provision for Income Taxes
Net Income After Taxes	-8,485	-7,910	-20,159	-273	-23,413
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-7,443	1,088	-19,418	-273	-23,413
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-7,443	1,088	-19,418	-273	-23,413
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-3,264	-703	-2,738	-1,047	-2,364
Dividends per Share